3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
23
Sexuality
1
Sexual Dysfunction, Physiological
1
Recurrence
1
Prostatic Hyperplasia
1
Postoperative Complications
1
Lymphocele
1
Infertility
1
Disease
1
Adenocarcinoma
1
Interventions
Radiotherapy
2
polyphenon E
1
mirabegron
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Transurethral Resection of Prostate
1
Transurethral Resection of Bladder
1
Therapeutics
1
Tamsulosin
1
Risedronic Acid
1
Prostatectomy
1
Prostate-Specific Antigen
1
Papaverine
1
Oxygen
1
Nitrous Oxide
1
Needles
1
Microspheres
1
Levofloxacin
1
Electroacupuncture
1
Dutasteride
1
Doxazosin
1
Diclofenac
1
Dexmedetomidine
1
Cystoscopy
1
Celecoxib
1
Catheters, Indwelling
1
Botulinum Toxins, Type A
1
Blood Specimen Collection
1
Amyloid
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostatic Hyperplasia
×
Prostatectomy
×
Clear all
NCT02873117
2018-02-26
CANARI
Rennes University Hospital
Completed
5,154 enrolled